Bio Protocol vs SuperRare — how do they compare? Bio Protocol trades at Rp442.29 (market cap Rp1T, Rp162,69M 24h volume), while SuperRare trades at Rp206.77 (market cap Rp170,92M, Rp215,75M 24h volume). The key difference: Bio Protocol is far larger — about 5850.7× SuperRare's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 825,5M / 1B RARE (83%) for SuperRare. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and SuperRare for 32 Days on average.
| BIO | RARE | |
|---|---|---|
Market Cap | Rp1T | Rp170,92M |
Volume (24h) | Rp162,69M | Rp215,75M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 825,5M / 1B RARE (83%) |
Typical Hold Time | 18 Days | 32 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
SuperRare (RARE) is currently trading at Rp211.64 with a market cap of Rp173.29M, showing bearish technical signals overall despite oscillators suggesting some bullish momentum. The token faces resistance at Rp217 (pivot point) with support at Rp200. With 83% of max supply in circulation and average hold time of 32 days, the asset demonstrates moderate network participation. Recent trading activity indicates consolidation below key resistance levels.
Overall outlook remains cautious with bearish pressure from moving averages outweighing oscillator signals. Key opportunity lies in potential breakout above Rp217 resistance, while major risks include low liquidity and crypto market volatility. Investors should monitor on-chain activity and exchange volume for directional cues.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →SuperRare is the leading curated marketplace for on-chain art, with more than US$300M in total sales and US$180M earned by artists. As one of the earliest champions of perpetual artist royalties, SuperRare is working to improve discovery while decentralizing the art market. Core to SuperRare is $RARE, a token offering utility as a currency on the marketplace, a staking-based reputation system, and DAO governance rights.
Read more on RARE →